Advertisement

Corrigendum Free access | 10.1172/JCI87364

Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects

John S. Millar, Gissette Reyes-Soffer, Patricia Jumes, Richard L. Dunbar, Emil M. deGoma, Amanda L. Baer, Wahida Karmally, Daniel S. Donovan, Hashmi Rafeek, Laura Pollan, Junichiro Tohyama, Amy O. Johnson-Levonas, John A. Wagner, Stephen Holleran, Joseph Obunike, Yang Liu, Rajasekhar Ramakrishnan, Michael E. Lassman, David E. Gutstein, Henry N. Ginsberg, and Daniel J. Rader

Find articles by Millar, J. in: PubMed | Google Scholar

Find articles by Reyes-Soffer, G. in: PubMed | Google Scholar

Find articles by Jumes, P. in: PubMed | Google Scholar

Find articles by Dunbar, R. in: PubMed | Google Scholar

Find articles by deGoma, E. in: PubMed | Google Scholar

Find articles by Baer, A. in: PubMed | Google Scholar

Find articles by Karmally, W. in: PubMed | Google Scholar

Find articles by Donovan, D. in: PubMed | Google Scholar

Find articles by Rafeek, H. in: PubMed | Google Scholar

Find articles by Pollan, L. in: PubMed | Google Scholar

Find articles by Tohyama, J. in: PubMed | Google Scholar

Find articles by Johnson-Levonas, A. in: PubMed | Google Scholar

Find articles by Wagner, J. in: PubMed | Google Scholar

Find articles by Holleran, S. in: PubMed | Google Scholar

Find articles by Obunike, J. in: PubMed | Google Scholar

Find articles by Liu, Y. in: PubMed | Google Scholar

Find articles by Ramakrishnan, R. in: PubMed | Google Scholar

Find articles by Lassman, M. in: PubMed | Google Scholar

Find articles by Gutstein, D. in: PubMed | Google Scholar

Find articles by Ginsberg, H. in: PubMed | Google Scholar

Find articles by Rader, D. in: PubMed | Google Scholar

Published April 1, 2016 - More info

Published in Volume 126, Issue 4 on April 1, 2016
J Clin Invest. 2016;126(4):1603–1604. https://doi.org/10.1172/JCI87364.
Copyright © 2016, American Society for Clinical Investigation
Published April 1, 2016 - Version history
View PDF

Related article:

Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects
John S. Millar, Gissette Reyes-Soffer, Patricia Jumes, Richard L. Dunbar, Emil M. deGoma, Amanda L. Baer, Wahida Karmally, Daniel S. Donovan, Hashmi Rafeek, Laura Pollan, Junichiro Tohyama, Amy O. Johnson-Levonas, John A. Wagner, Stephen Holleran, Joseph Obunike, Yang Liu, Rajasekhar Ramakrishnan, Michael E. Lassman, David E. Gutstein, Henry N. Ginsberg, Daniel J. Rader
John S. Millar, Gissette Reyes-Soffer, Patricia Jumes, Richard L. Dunbar, Emil M. deGoma, Amanda L. Baer, Wahida Karmally, Daniel S. Donovan, Hashmi Rafeek, Laura Pollan, Junichiro Tohyama, Amy O. Johnson-Levonas, John A. Wagner, Stephen Holleran, Joseph Obunike, Yang Liu, Rajasekhar Ramakrishnan, Michael E. Lassman, David E. Gutstein, Henry N. Ginsberg, Daniel J. Rader
Corrigendum

Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects

Abstract

Authors

John S. Millar, Gissette Reyes-Soffer, Patricia Jumes, Richard L. Dunbar, Emil M. deGoma, Amanda L. Baer, Wahida Karmally, Daniel S. Donovan, Hashmi Rafeek, Laura Pollan, Junichiro Tohyama, Amy O. Johnson-Levonas, John A. Wagner, Stephen Holleran, Joseph Obunike, Yang Liu, Rajasekhar Ramakrishnan, Michael E. Lassman, David E. Gutstein, Henry N. Ginsberg, Daniel J. Rader

×

Original citation: J Clin Invest. 2015;125(6):2510–2522. doi:10.1172/JCI80025.

Citation for this corrigendum: J Clin Invest. 2016;126(4):1603–1604. doi:10.1172/JCI87364.

In Table 4, the units for ApoC-III conc. were incorrect. The correct table is below.

Table 4

Factors known to be associated with ApoB clearance: mean baseline values, percentage change from baseline, and between-period differences for subjects in the total population and by panel

The authors regret the error.

Footnotes

See the related article beginning on page 2510.

Version history
  • Version 1 (April 1, 2016): No description
Advertisement
Advertisement